NINDS Neuroscience Funding Announcements

Funding Resources
Funding Overview
Funding Strategy

Funding Opportunities

Grant Mechanisms
Training & Career
Development
Contracts Management
Review Committees
Funding News
Program Areas

Research
Anticonvulsant Screening
   Program
Clinical Research
Counterterrorism
Epilepsy Research Web
Neural Interfaces Program
NIH Roadmap Research
Parkinson's Web
Resources for Scientists
Stem Cell Research
Translational Research
Traumatic Brain Injury
   (TBI) Research
Technology Transfer
   Office

NINDS is part of the
National Institutes of
Health

Download Adobe Reader

Print-friendly version

Email this page

Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transition by registering with Grants.gov and NIH eRA Commons now.

Small Business Technology Transfer to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D) and its Complications (STTR [R41/R42])
Release Date: October 18, 2005
Announcement Number: RFA-DK-05-015
Application Receipt Date:
March 15, 2006
Letter of Intent Date: February 15, 2006

Funding Contact: John Porter, Ph.D.
Program Area: Channels, Synapses and Neural Circuits

Brief Description:
The National Institute of Diabetes, Digestive and Kidney diseases (NIDDK), National Eye Institute (NEI), National Heart, Lung, and Blood Institute (NHLBI), National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Neurological Disorders and Stroke (NINDS) and National Institute of Child Health and Human development (NICHD) invite the small business community to apply cutting edge technology to investigate the development of new approaches to predict, prevent, treat, and cure type 1 Diabetes (T1D) and its complications. The total funds available will be approximately $4,000,000 in FY2006

Choose an option to view additional funding announcements